Tata Chemicals Limited Opens Special Window for Physical Share Transfer Re-lodgement

2 min read     Updated on 17 Mar 2026, 08:07 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Tata Chemicals Limited has opened a special window from February 5, 2026 to February 4, 2027 for re-lodgement of physical share transfer requests that were previously rejected due to document deficiencies. The facility applies to requests originally lodged prior to April 1, 2019, with re-lodged shares to be issued in demat mode under one-year lock-in. Shareholders must submit documents to MUFIS India Private Limited, with exclusions for disputed cases and IEPF-transferred shares.

35303826

*this image is generated using AI for illustrative purposes only.

Tata Chemicals Limited has announced the opening of a special window for shareholders to re-lodge transfer requests of physical shares that were previously rejected or returned due to document deficiencies. The initiative demonstrates the company's commitment to facilitating seamless share transfer processes for its stakeholders.

Special Window Details

Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has opened another special window from February 5, 2026 to February 4, 2027. This facility is specifically designed for re-lodgement of transfer requests which were lodged prior to April 1, 2019 for transfer of physical shares and were rejected, returned, or not attended to due to deficiency in documents, process, or otherwise.

Parameter Details
Window Period February 5, 2026 to February 4, 2027
Applicable Requests Transfer requests lodged prior to April 1, 2019
Share Mode Physical shares only
Processing Basis SEBI Circular dated January 30, 2026

Share Transfer Conditions

The shares that are re-lodged for transfer under this special window will be issued only in demat mode and will be subject to a lock-in period of one year from the date of registration of transfer. This requirement aligns with current regulatory frameworks promoting dematerialization of securities.

Exclusions and Limitations

Certain categories of cases will not be considered under this special window. Cases involving disputes between transferor and transferee shall not be processed and may need to be settled through Court or NCLT process. Additionally, shares which have been transferred to Investor Education and Protection Fund will not be considered under this window for processing.

Submission Process

Eligible shareholders are required to submit necessary original transfer documents along with corrected or missing details and other requisite documents to the Company's Registrar and Transfer Agent, MUFIS India Private Limited. The documents should be submitted at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083.

Contact Details Information
Registrar & Transfer Agent MUFIS India Private Limited
Address C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083
Contact Number +91 8168116767
Service Request Portal https://web.in.mpfms.mufis.com/helpdesk/Service-Request.html

Public Notification

The company has published newspaper advertisements regarding this special window in multiple publications on March 17, 2026, including Business Standard (English), The Free Press Journal (English), and Navshakti (Marathi). The information is also available on the company's website at www.tatachemicals.com .

The communication was signed by Jeraz E. Mahernosh, Company Secretary (FCS 7008), and digitally signed on March 17, 2026. This initiative reflects the company's proactive approach to addressing shareholder concerns and facilitating efficient share transfer processes within the regulatory framework.

Source: None/Company/INE092A01019/0789556e-8322-40a2-a0fe-aae9ec750c2e.pdf

Historical Stock Returns for Tata Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.97%-5.88%-8.81%-35.29%-22.82%-14.50%

Tata Chemicals Q3FY26 Results: Loss Widens to ₹690M Amid Soda Ash Market Pressures

4 min read     Updated on 06 Feb 2026, 11:26 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Tata Chemicals' Q3FY26 results showed widened losses due to challenging soda ash market conditions with oversupply and pricing pressures. Despite consolidated performance decline, standalone operations showed resilience with volume growth and cost management. The company approved strategic investments including ₹515 crore for salt facility expansion and acquired Novabay Singapore to strengthen bicarbonate market position.

31576899

*this image is generated using AI for illustrative purposes only.

Tata Chemicals has published its Q3FY26 quarterly results in leading newspapers following the Board of Directors' approval on February 2, 2026. The chemical manufacturer reported a consolidated net loss of ₹690 million compared to a loss of ₹210 million in the corresponding quarter of the previous year, while revenue from operations declined to ₹3,550 crore from ₹3,590 crore year-on-year.

Financial Performance Overview

The company's third-quarter results demonstrate challenging operational conditions across key financial metrics. The consolidated net loss widened significantly, while revenue experienced a marginal decline during the reporting period.

Financial Metric: Q3 FY26 Q3 FY25 Change
Consolidated Net Loss: ₹690 million ₹210 million Loss widened by ₹480 million
Revenue from Operations: ₹3,550 crore ₹3,590 crore Declined by 1%
EBITDA: ₹345 crore ₹434 crore Declined by ₹89 crore
EBITDA Margin: 9.72% 12.09% Compressed by 237 basis points

Management Commentary on Market Conditions

During the earnings conference call held on February 2, 2026, R. Mukundan, Managing Director & CEO, provided detailed insights into the challenging market environment. He stated that soda ash markets continue to remain oversupplied, with high inventory levels across most regions. Prices softened further during Q3FY26, reflecting adverse demand-supply dynamics.

The company highlighted that global soda ash demand growth remains tepid and flat in the near term, constrained by weak macroeconomics in Southeast Asia and parts of Asia. This has been primarily driven by export restrictions and constraints in one of the biggest markets in the U.S.

Market Conditions: Current Status
Global Inventory Levels: Elevated across regions
China Inventory: 1.5 million tonnes
Chinese Price Decline: 54% between Q3FY23 and Q3FY26
Current China Domestic Price: CNY 1,200

Standalone Performance Highlights

Despite market headwinds, the company's standalone performance was supported by higher volumes and disciplined cost management. The standalone revenue from operations stood at ₹1,204 crore, up 3% compared to Q3FY25 due to higher volumes.

Standalone Metrics: Q3 FY26 Q3 FY25 Change
Revenue from Operations: ₹1,204 crore ₹1,169 crore Up 3%
EBITDA: ₹228 crore ₹209 crore Up 9%
PAT (before exceptional items): ₹87 crore ₹72 crore Up 21%

Strategic Investments and Capacity Expansions

The Board approved significant investments to strengthen the company's position in growing markets. A major investment of ₹515 crore was approved for setting up a greenfield manufacturing facility for Iodised Vacuum Salt Dried (IVSD) at Valinokkam, Ramanathapuram district, Tamil Nadu, with a capacity of 210 kilo tonnes per annum.

Investment Details: Specifications
IVSD Facility Investment: ₹515 crore
Capacity: 210 KTPA
Location: Valinokkam, Tamil Nadu
Timeline: 36 months

During the quarter, the company commissioned Pearl Silica facility with a capacity of 3,000 MTPA at Cuddalore, Tamil Nadu, and FOS L55 facility with a capacity of 4,500 MTPA at Mambattu. The Board also approved a 50 kilo tonne per annum precipitated silica expansion at Cuddalore at an investment of ₹775 crore.

Exceptional Items and Regulatory Impact

The company recorded exceptional items totaling ₹54 crore during the quarter related to the implementation of new Labour Codes notified by the Government of India. These codes consolidate existing labour laws and primarily impact gratuity liability calculations due to changes in wage definitions.

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, the company reported revenue from operations of ₹11,146 crore, down by 2% compared to the corresponding period of the previous year. EBITDA stood at ₹1,531 crore compared to ₹1,626 crore in 9MFY25.

Nine-Month Metrics: FY26 (9M) FY25 (9M) Change
Revenue from Operations: ₹11,146 crore ₹11,378 crore Declined by 2%
EBITDA: ₹1,531 crore ₹1,626 crore Declined by ₹95 crore
Profit After Tax (before exceptional items): ₹520 crore ₹491 crore Increased by ₹29 crore

Strategic Acquisitions and Market Positioning

The company announced the acquisition of Novabay Singapore on December 19, entering into a share purchase agreement. This acquisition strengthens Tata Chemicals' position in the premium grade value-added bicarbonate market by expanding geographic footprint from UK serving European markets to include Asian markets, including ASEAN and Far East.

Regulatory Filings and Transparency

The company published its unaudited consolidated and audited standalone financial results in multiple newspapers on February 3, 2026, including Business Standard, The Free Press Journal, and Navshakti (Marathi). The earnings conference call transcript was subsequently filed with stock exchanges on February 6, 2026, ensuring comprehensive disclosure to stakeholders.

Historical Stock Returns for Tata Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.97%-5.88%-8.81%-35.29%-22.82%-14.50%

More News on Tata Chemicals

1 Year Returns:-22.82%